Erudio Healtherudio.com
Drug
Bcg trials: what clinicians said in public
No HCP commentary report on a trial studying bcg yet. Erudio has found public clinician commentary on 4 clinical trials studying bcg: ALBAN, CheckMate 9UT, KEYNOTE-676 and PATAPSCO. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| ALBAN NCT03799835 · UNICANCER DeepView → | BCG-naive high-risk non-muscle-invasive bladder cancer | Phase 3 | Deep | View | |||
| KEYNOTE-676 NCT03711032 · Merck Sharp & Dohme LLC DeepView → | high-risk non-muscle invasive bladder cancer | Phase 3 | Deep | View | |||
| PATAPSCO NCT05943106 · AstraZeneca StandardView → | BCG-naïve, high-risk non-muscle-invasive bladder cancer | Phase 3 | Standard | View | |||
| CheckMate 9UT NCT03519256 · Bristol-Myers Squibb FocusedView → | BCG-unresponsive high-risk non-muscle invasive bladder cancer | Phase 2 | Focused | View | |||